KevinMD January 1, 2026
For decades, medicine has spoken the language of hazard ratios, Kaplan-Meier curves, and median survival differences. We have become fluent in the grammar of precision oncology, genomic signatures, driver mutations, targeted therapeutics, and real-time disease monitoring. But there is one language we have not yet mastered: the language of the patient’s lived experience.
Personalized medicine cannot stop at matching the right drug to the right tumor. It must also include personalized scientific communication, translating clinical outcomes into the rhythms of a patient’s real life.
When a trial shows a one-year improvement in survival, we call it “statistically significant.” But for a patient, that year could mean something far deeper:
- One more Christmas tree to decorate with their children.
- One...
Today's Sponsors
Today's Sponsor